5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials
    Journal Article

    Atkins, K. M.; Chen, M. H.; Wu, J.; Renshaw, A. A.; Loffredo, M.; Kantoff, P. W.; Small, E. J.; D'Amico, A. V.
    Cancer (2018)

    Fulltext@MSK | Save
  • Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators
    Journal Article

    Boustani, J.; Bertaut, A.; Galsky, M. D.; Rosenberg, J. E.; Bellmunt, J.; Powles, T.; Recine, F.; Harshman, L. C.; Chowdhury, S.; Niegisch, G.; more...
    Acta Oncologica (2018)

    Fulltext@MSK | Save
  • Treatment of CD30-expressing germ cell tumors and sex cord stromal tumors with brentuximab vedotin: Identification and report of seven cases
    Journal Article

    Albany, C.; Einhorn, L.; Garbo, L.; Boyd, T.; Josephson, N.; Feldman, D. R.
    The Oncologist (2018)

    Fulltext@MSK | Save
  • Drug development for noncastrate prostate cancer in a changed therapeutic landscape
    Journal Article

    Teo, M. Y.; O'Shaughnessy, M. J.; McBride, S. M.; Vargas, H. A.; Scher, H. I.
    Nature Reviews Clinical Oncology (2018)

    Fulltext@MSK | Save
  • TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
    Journal Article

    Mariathasan, S.; Turley, S. J.; Nickles, D.; Castiglioni, A.; Yuen, K.; Wang, Y.; Kadel, E. E. 3rd; Koeppen, H.; Astarita, J. L.; Cubas, R.; more...
    Nature (2018)

    Fulltext@MSK | Save
  • Quality of life outcomes for cabozantinib versus everolimus in patients with metastatic renal cell carcinoma: METEOR phase III randomized trial
    Journal Article

    Cella, D.; Escudier, B.; Tannir, N. M.; Powles, T.; Donskov, F.; Peltola, K.; Schmidinger, M.; Heng, D. Y. C.; Mainwaring, P. N.; Hammers, H. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Cabozantinib, a new standard of care for patients with advanced renal cell carcinoma and bone metastases? Subgroup analysis of the METEOR trial
    Journal Article

    Escudier, B.; Powles, T.; Motzer, R. J.; Olencki, T.; Frontera, O. A.; Oudard, S.; Rolland, F.; Tomczak, P.; Castellano, D.; Appleman, L. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clinical and genetic risk factors for adverse metabolic outcomes in North American testicular cancer survivors
    Journal Article

    Zaid, M. A.; Gathirua-Mwangi, W. G.; Fung, C.; Monahan, P. O.; El-Charif, O.; Williams, A. M.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Beard, C. J.; more...
    Journal of the National Comprehensive Cancer Network (2018)

    Fulltext@MSK | Save
  • Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update
    Journal Article

    Choueiri, T. K.; Hessel, C.; Halabi, S.; Sanford, B.; Michaelson, M. D.; Hahn, O.; Walsh, M.; Olencki, T.; Picus, J.; Small, E. J.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save